Module 1.2.2 (Management of Anxiety) Flashcards
Why do anxiety disorders require ongoing treatment?
Axiety disorders are usually relapsing and chronic
What are the THREE steps to general principles of management of anxiety disorders?
Step 1: Confirm diagnosis
- History assessment
- Physical examination to exclude underlying medical cause
- Identify features to define specific anxiety disorder (&/or co-existing psychiatric disorders)
- Assess degree of distress
Step 2: Identify and address factors that may exccerbate the disorder
- Psychological factors
- Lifestyle factors
Step 3: Initiate therapy –> if reuquired
- Psychoeducation
- Psychological treatments
- Pharmacological management
What TWO types of exacerbating agents to avoid? Provide examples
- Psychological factors
- Financial difficulties
- Relationship difficulties
- Lifestyle factors
- Alcohol, nicotine and illicit drug use
- Excessive caffeine intake
- Excessive work
- Inadequate sleep
What is psychoeducation about? What treatment options does it lead into?
- The nature of the anxiety
- It’s purpose
- How it can present
leads into relaxation techniques, yoga, exercise, CBT
Psychological interventions are the most appropriate initial treatment choice in most cases. What do psychological interventions include?
- Cognitive behavioural therapy (CBT)
- Exposure therapy
- & many others
Many treatments are available as self-help therapies on-line and are referred to as e-therapy
For Cognitive Behavioural Therapy (CBT) –> most effective therapy for anxiety 1st line intervention
A) What is the focus on?
B) Based on what 2 key principles
C) How many sessions are there
D) What interferes with the effectiveness
A)
Focus is on changing maladaptive thinking patterns and behaviour
B)
- Cognitions may control feelings and behaviour
- Behaviours may affect thought patterns and emotions
C)
- Acute treatment 12 – 20 weekly sessions
> Individual, group therapy or selfdirected formats
> Follow-up booster sessions after 3 or 6 months useful
D)
- Benzodiazepine
What is exposure therapy? What anxiety coniditons is it useful for?
Based on the principle of respondent conditioning
- Can be useful for PTSD, OCD and specific phobias
> Also, social phobia and panic disorder
> Sometimes used together with CBT
- When people are fearful of something they often avoid what they fear however in the long term this can make fears worse
- Exposure therapy = “Face fears” and challenge them in a controlled way
> can be done using virtual reality
What is E-therapy for?
Generally CBT-based treatment approach
> Can be as effective as face-to-face therapies
- Mood gym
- Mindsport courses
- E-couch programmes
For pharmacotherapy for anxiety (used when psychological interventions are ineffective or not available):
A) What is first line?
B) What is used in exceptional circumstances?
C) What are other drugs used in anxiety?
A)
- SSRIs (for all anxiety disorders) + SNRIs for some disorders
B)
- Benzodiazepines
C)
- TCAs
- MAOIs
- Buspirone
- Anticonvulsants
- Anttipsychotics
- Beta-blockers
For the follwowing anxiety disorders;
A) What drugs are used for GAD
B) What drugs are used for SAD
C) What drugs are used for panic disorder
D) What drugs are used for specific phobias
E) what drugs are used for OCD
F) What drugs are used for PTSD
A)
- An SSRI or duloxetine or venlafaxine
- imipramine or buspirone
B)
- An SSRI or venlafaxine
C)
1. An SSRI or venlafaxine
- clomipramine or imipramine
D)
No ongoing pharmacotherapy recommended
E)
- An SSRI
- clomipramine
F)
- An SSRI
- mirtazepine or amitriptyline
What is the MOA of SSRIs? What are the examples of them (CEFFPS)
Selectively inhibit the pre-synaptic reuptake of serotonin (5-hydroxytrytamine, 5HT)
- Citalopram
- Escitalopram
- Fluoxetine
- Fluvoxamine
- Paroxetine
- Sertraline
What SSRIs and SNRIs are recommended for:
A) General Anxiety Disorder (GAD)
B) Social Anxiety Disorder (SAD)
C) Panic disorder
D) OCD
E) PTSD
A)
- Escitalopram, paroxetine, venlafaxine, duloxetine,
B)
- Escitalopram, paroxetine, sertraline, venlafaxine
C)
- Citalopram*, fluoxetine*, fluvoxamine*, paroxetine, sertraline, venlafaxine
D)
- Citalopram*, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline
E)
- Fluoxetine*, paroxetine
* Not approved by TGA for indication listed in AMH
All SSRI have similar efficacy, not every SSRI has TGA approval for each anxiety disorder, thus a favourable tolerability profile should be chosen. What qualities does the below SSRIs have?
A) Citalopram, escitalopram and sertraline
B) Paroxetine
C) Fluoxetine
D) Citalopram, fluoxetine and escitalopram
A)
least potential for drug interactions by inhibition of CYP enzymes
B)
shortest half-life and no active metabolite. Highest potential for withdrawal symptoms
C)
Active metabolite and has a long half-life (up to 16 days). Adverse effects and interactions may persist after treatment is stopped. Low incidence of withdrawal symptoms
D)
May increase the QT interval
All SSRIs have similar adverse effects and are relatively safe in overdose
How to dose SSRIs in patients who have anxiety? What is seen when starting SSRIS? What is the onset of action?
Start patients on half the minimum strength tablet available –> continue at that dose for a few days to a week until patient feels confident enough to increase dose
- Increased anxiety when starting SSRIs
- Onset of action is slower for anxiety (4-6 weeks)
Why avoid high maintanence doses for anxiety patients on SSRIs?
Activating effects may exacerbate anxiety.